Filter
4113
Filtered Results: 4113
Text search:
the
90-90-90
target
Featured
Recommendations
338
New Publications
1307
Language
Document type
No document type
2617
Studies & Reports
732
Guidelines
370
Strategic & Response Plan
146
Manuals
115
Fact sheets
41
Training Material
39
Situation Updates
30
Infographics
14
Brochures
5
Resource Platforms
4
Countries / Regions
India
190
Global
170
Kenya
141
Ethiopia
111
Nepal
102
Uganda
92
Nigeria
86
Myanmar / Burma
85
Sierra Leone
84
Liberia
82
South Africa
79
Zambia
77
Rwanda
74
Malawi
74
Bangladesh
72
Africa
70
Ghana
66
Syria
66
Western and Central Europe
64
Tanzania
62
Latin America and the Carribbean
54
Philippines
49
Congo, Democratic Republic of
46
Indonesia
45
Namibia
43
Ukraine
39
Asia
39
Lesotho
34
South Sudan
33
Cambodia
33
South–East Asia Region
32
Mozambique
29
Senegal
28
Zimbabwe
28
Eastern Europe
27
Botswana
23
Yemen
21
East and Southern Africa
21
Pakistan
20
West and Central Africa
20
Haiti
18
Guinea
17
Jordan
17
Afghanistan
17
Venezuela
17
Burkina Faso
16
Germany
14
Lebanon
13
Eswatini/ Swaziland
13
Cameroon
12
Brazil
12
Somalia
11
Russia
11
Benin
10
Colombia
10
Middle East and North Africa
10
Sudan
9
Central African Republic
9
Albania
9
Thailand
8
Western Pacific Region
8
Eastern Europe and Central Asia
8
Mali
7
Turkey
7
Paraguay
7
Peru
6
Sri Lanka
6
Chile
6
Palestine
6
Southern Africa
6
Tajikistan
6
Moldova
6
Georgia
6
USA
5
Iraq
5
China
5
Argentina
5
Vietnam
5
North America
5
Côte d’Ivoire / Ivory Coast
4
Egypt
4
El Salvador
4
Madagascar
4
Timor Leste/ East Timor
4
Iran
4
Togo
3
North Macedonia
3
Serbia
3
Ecuador
3
Libya
3
Angola
3
Armenia
3
Kyrgyzstan
3
Kazakhstan
3
Saudi Arabia
2
Chad
2
Gambia
2
Papua New Guinea
2
Burundi
2
Bolivia
2
Mexico
2
Bhutan
2
Djibouti
2
Laos
2
Qatar
2
Guinea-Bissau
1
Morocco
1
Niger
1
Mauritania
1
Ireland
1
Singapore
1
Honduras
1
Greece
1
Guatemala
1
Other region
1
Fiji
1
Poland
1
North Korea
1
Italy
1
Congo-Brazzaville
1
Bulgaria
1
Estonia
1
Lithuania
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
Tunisia
1
United Kingdom
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
1835
Clinical Guidelines
315
Public Health
213
Women & Child Health
185
Key Resources
125
Capacity Building
44
Pharmacy & Technologies
41
Annual Report MEDBOX
2
Toolboxes
HIV
442
TB
240
COVID-19
239
Mental Health
225
Conflict
131
Planetary Health
121
Disability
116
AMR
110
NTDs
94
Ebola
92
NCDs
91
Rapid Response
73
Global Health Education
65
Caregiver
59
Refugee
57
Health Financing Toolbox
43
Pharmacy
42
Natural Hazards
38
Polio
34
Cholera
25
Specific Hazards
16
Zika
5
Typhoon
4
Social Ethics
3
South Sudan
2
Health Financing
2
This treatment guideline is intended to assist clinicians in the Behavioral Health department in treatment planning and service delivery for patients with Post Traumatic Stress Disorder (PTSD). It may also assist clinicians treating patients who hav...
Q6: Can dementia be diagnosed at first or second level care by non-specialist health care providers? What should be the assessment process for the diagnosis of dementia?
Technical guidance.
This technical guidance aims to inform policy and practice development specifically related to improving the health of older refugees and migrants within the European Union and ...
Antimicrobial resistance (AMR) is a complex issue of global concern. AMR is not simply a problem of medical science being beaten by nature; human action and perverse incentives play a major role in its development. The misuse of antibiotics in ... medical, veterinary and agricultural sectors, which include the inappropriate prescribing of antibiotics, their overuse in the livestock sector, and insufficient hygiene practices in hospital, all contribute to the rise of AMR.
Antimicrobial resistance (AMR) is a complex issue of global concern. AMR is not simply a problem of medical science being beaten by nature; human action and perverse incentives play a major role in its development. The misuse of antibiotics in ... medical, veterinary and agricultural sectors, which include the inappropriate prescribing of antibiotics, their overuse in the livestock sector, and insufficient hygiene practices in hospital, all contribute to the rise of AMR
This FY 2019 Malaria Operational Plan presents a detailed implementation plan for Burkina Faso, based on the strategies of PMI and the National Malaria Control Program (NMCP). It was developed in co...
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric ...
4 April 2020
This interim guidance on oxygen sources and distribution strategies for COVID-19 treatment has been adapted from WHO and UNICEF’s technical specifications and guidance for oxygen therapy devices, which is part of the WHO medical devi...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that ... systematic neglect of cultural factors is one of the biggest obstacles to achieving better health outcomes and better standards of living worldwide. Using a cultural contexts of health approach, the policy brief explores the centrality of culture to the challenge of ABR. The brief examines how the prescription and use of antibacterial medicines, the transmission of resistance, and the regulation and funding of research are influenced by cultural, social and commercial, as well as biological and technological factors. The brief moves beyond the ready equation of culture with individual behaviours and demonstrates how culture serve as an enabler of health and provide new possibilities for change.
Primary care health centers and providers who care for individuals with hypertension and cardiovascular disease have an important role to play in ensuring continued access to care, reducing the risk of coronavirus infection, and appropriately managi...
Millions of children in Yemen could be pushed to ‘the brink of starvation’ due to huge shortfalls in humanitarian aid funding amid the COVID-19 pandemic – according to a new UNICEF report mark...
Organizing and Delivering High Quality Care for Chronic Noncommunicable Diseases in the Americas
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients ...
Ethiopia saw a six-fold increase in confirmed COVID-19 cases between June and August, with 5,689 cases by end June compared to 34,058 cases as of 19 August. Ethiopia also registered more than 13,000 recoveries and more than 600 deaths. As of the las...
Zoonotic tuberculosis (TB) is a form of TB in people predominantly caused by the bacterial species, Mycobacterium bovis, which belongs to the M. tuberculosis complex. ... implications of zoonotic TB go beyond human health. The organism is host-adapted to cattle, where it is referred to as bovine TB, and it also causes TB in other animal species including wildlife. Bovine TB has an important economic impact and threatenslivelihoods.
Malaria Journal (2018) 17:460 https://doi.org/10.1186/s12936-018-2606-9
In malaria endemic countries, asymptomatic cases constitute an important reservoir of infections sustaining transmission. Estimating the burden of ... asymptomatic population and identifying areas with elevated risk is important for malaria control in Burkina Faso.
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middl...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, ... report provides updates on the various dimensions of access to HCV diagnostics and pharmaceutical products, including product pricing, the regulatory environment and patent status, which together shape the national hepatitis response in different settings. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners.
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in...
